title: Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder.
abstract: There is abundant evidence that dysfunction of the γ-aminobutyric acid (GABA)ergic signaling system is implicated in the pathology of schizophrenia and mood disorders. Less is known about the alterations in protein expression of GABA receptor subunits in brains of subjects with schizophrenia and mood disorders. We have previously demonstrated reduced expression of GABA(B) receptor subunits 1 and 2 (GABBR1 and GABBR2) in the lateral cerebella of subjects with schizophrenia, bipolar disorder and major depressive disorder. In the current study, we have expanded these studies to examine the mRNA and protein expression of 12 GABA(A) subunit proteins (α1, α2, α3, α5, α6, β1, β2, β3, δ, ε, γ2 and γ3) in the lateral cerebella from the same set of subjects with schizophrenia (N=9-15), bipolar disorder (N=10-15) and major depression (N=12-15) versus healthy controls (N=10-15). We found significant group effects for protein levels of the α2-, β1- and ε-subunits across treatment groups. We also found a significant group effect for mRNA levels of the α1-subunit across treatment groups. New avenues for treatment, such as the use of neurosteroids to promote GABA modulation, could potentially ameliorate GABAergic dysfunction in these disorders.
authors.affiliation: 1] Division of Neuroscience Research, Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA [2] Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN, USA [3] Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.
authors.forename: S H
authors.initials: SH
authors.lastname: Fatemi
authors.forename: T D
authors.initials: TD
authors.lastname: Folsom
authors.forename: R J
authors.initials: RJ
authors.lastname: Rooney
authors.forename: P D
authors.initials: PD
authors.lastname: Thuras
mesh_terms: D000328:Adult; D001714:Bipolar Disorder / Q000235:genetics / Q000378:metabolism*; D016022:Case-Control Studies; D002531:Cerebellum / Q000378:metabolism*; D003865:Major Depressive Disorder / Q000235:genetics / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000032:analysis*; D060888:Real-Time Polymerase Chain Reaction; D011963:Receptors, GABA-A / Q000235:genetics / Q000378:metabolism*; D012559:Schizophrenia / Q000235:genetics / Q000378:metabolism*
chemical_list: C484841:GABRA2 protein, human; C546264:GABRB1 protein, human; C546274:GABRE protein, human; D012333:RNA, Messenger; D011963:Receptors, GABA-A
references.citation: Mol Psychiatry. 2008 Feb;13(2):147-61
references.pmid: 17471287
references.citation: Neuropharmacology. 2009 Oct-Nov;57(5-6):481-95
references.pmid: 19631671
references.citation: Ann N Y Acad Sci. 1995 May 10;757:506-15
references.pmid: 7611708
references.citation: Hum Brain Mapp. 2001 Apr;12(4):219-31
references.pmid: 11241873
references.citation: Neuropsychobiology. 2001;43(3):141-4
references.pmid: 11287792
references.citation: Schizophr Res. 2009 Apr;109(1-3):94-7
references.pmid: 19268543
references.citation: Biol Psychiatry. 2002 Mar 1;51(5):370-6
references.pmid: 11904131
references.citation: J Neurosci. 1992 Mar;12(3):1063-76
references.pmid: 1312132
references.citation: Cerebellum. 2009 Mar;8(1):64-9
references.pmid: 19002745
references.citation: Mol Psychiatry. 2005 Dec;10(12):1074-88, 1057
references.pmid: 16172613
references.citation: ScientificWorldJournal. 2010 Nov 04;10:2198-206
references.pmid: 21057732
references.citation: J Autism Dev Disord. 2010 Jun;40(6):743-50
references.pmid: 20066485
references.citation: Am J Psychiatry. 2008 Dec;165(12):1594-603
references.pmid: 18923069
references.citation: Psychopharmacology (Berl). 2006 Jun;186(3):362-72
references.pmid: 16432684
references.citation: Hum Mol Genet. 2005 Feb 15;14(4):483-92
references.pmid: 15615769
references.citation: Biol Psychiatry. 2010 Jan 1;67(1):20-7
references.pmid: 19833324
references.citation: Biol Psychiatry. 2010 May 15;67(10):998-1001
references.pmid: 20189164
references.citation: Schizophr Res. 2005 Jan 1;72(2-3):109-22
references.pmid: 15560956
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):294-301
references.pmid: 22554588
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3239-44
references.pmid: 9501247
references.citation: Clin Pharmacol Ther. 2009 Oct;86(4):442-6
references.pmid: 19626000
references.citation: Neurochem Int. 2006 Nov;49(6):557-67
references.pmid: 16766085
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15718-23
references.pmid: 9861036
references.citation: Prog Neurobiol. 2002 Jun;67(2):113-59
references.pmid: 12126658
references.citation: Biol Psychiatry. 2011 Mar 1;69(5):442-9
references.pmid: 21145041
references.citation: Am J Psychiatry. 2002 Nov;159(11):1830-40
references.pmid: 12411216
references.citation: Psychopharmacology (Berl). 2007 Oct;194(3):361-9
references.pmid: 17604981
references.citation: Neuroscience. 1999;93(2):441-8
references.pmid: 10465426
references.citation: Biol Psychiatry. 2011 Mar 1;69(5):397-8
references.pmid: 21316514
references.citation: World J Biol Psychiatry. 2011 Feb;12(1):57-65
references.pmid: 21250934
references.citation: Psychiatr Genet. 1994 Fall;4(3):185-91
references.pmid: 7719705
references.citation: Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9985-90
references.pmid: 8790444
references.citation: Neurosci Lett. 2003 Sep 25;349(1):9-12
references.pmid: 12946574
references.citation: Mol Pharmacol. 1990 Apr;37(4):497-502
references.pmid: 2157958
references.citation: Am J Psychiatry. 2009 Apr;166(4):450-9
references.pmid: 19289452
references.citation: Neuroscience. 2002;111(3):657-69
references.pmid: 12031352
references.citation: J Psychiatr Res. 2008 Feb;42(3):184-91
references.pmid: 17207817
references.citation: Neural Plast. 2011;2011:723184
references.pmid: 21904685
references.citation: Pharmacogenomics. 2013 Feb;14(3):277-88
references.pmid: 23394390
references.citation: J Physiol. 2001 Nov 1;536(Pt 3):785-96
references.pmid: 11691872
references.citation: Behav Brain Res. 2011 Feb 2;217(1):77-80
references.pmid: 20965216
references.citation: Proteomics. 2011 Jun;11(11):2171-81
references.pmid: 21538884
references.citation: Biol Psychiatry. 2003 Dec 1;54(11):1274-83
references.pmid: 14643095
references.citation: Schizophr Res. 2008 Apr;101(1-3):36-49
references.pmid: 18394866
references.citation: J Psychiatr Res. 2010 Jul;44(10):673-81
references.pmid: 20100621
references.citation: Neuropharmacology. 2002 Sep;43(4):662-8
references.pmid: 12367611
references.citation: Schizophr Res. 2010 Dec;124(1-3):246-7
references.pmid: 20727716
references.citation: Br J Psychiatry. 2009 Jul;195(1):23-9
references.pmid: 19567891
references.citation: Cereb Cortex. 2011 May;21(5):999-1011
references.pmid: 20843900
references.citation: Biol Psychiatry. 2003 Sep 1;54(5):515-28
references.pmid: 12946880
references.citation: Neuron. 2000 Oct;28(1):53-67
references.pmid: 11086983
references.citation: Biochem Soc Trans. 2009 Dec;37(Pt 6):1415-8
references.pmid: 19909288
references.citation: Am J Psychiatry. 2008 Dec;165(12):1585-93
references.pmid: 18923067
references.citation: Genomics. 1995 Mar 20;26(2):258-64
references.pmid: 7601451
references.citation: Psychiatr Genet. 2006 Feb;16(1):9-17
references.pmid: 16395124
references.citation: Psychiatr Genet. 1998 Winter;8(4):251-4
references.pmid: 9861645
references.citation: Cortex. 2008 Sep;44(8):1037-66
references.pmid: 18614161
references.citation: Curr Opin Pharmacol. 2009 Feb;9(1):24-30
references.pmid: 19157982
references.citation: Psychiatr Genet. 2009 Apr;19(2):91-8
references.pmid: 19672139
references.citation: Mol Psychiatry. 2011 Apr;16(4):383-406
references.pmid: 21079608
references.citation: Neuropsychopharmacology. 2009 Jul;34(8):1885-903
references.pmid: 19339966
references.citation: Neuropsychopharmacology. 2011 Sep;36(10):2103-10
references.pmid: 21677653
references.citation: Biol Psychiatry. 2004 Jan 1;55(1):40-5
references.pmid: 14706423
references.citation: Eur J Neurosci. 2000 Dec;12(12):4318-30
references.pmid: 11122342
references.citation: Br J Psychiatry. 2002 Nov;181:411-5
references.pmid: 12411267
references.citation: Neuropharmacology. 2012 Jan;62(1):42-53
references.pmid: 21889518
references.citation: Schizophr Res. 2011 May;128(1-3):37-43
references.pmid: 21303731
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4746-51
references.pmid: 11296301
references.citation: J Magn Reson Imaging. 2011 Dec;34(6):1430-8
references.pmid: 21976249
references.citation: Int Rev Psychiatry. 2007 Aug;19(4):325-36
references.pmid: 17671866
references.citation: Biol Psychiatry. 2007 Mar 1;61(5):653-60
references.pmid: 16950232
references.citation: Eur Neuropsychopharmacol. 2013 Oct;23(10):1182-9
references.pmid: 23332465
references.citation: J Psychiatry Neurosci. 2005 May;30(3):178-86
references.pmid: 15944742
references.citation: Clinics (Sao Paulo). 2011;66 Suppl 1:71-7
references.pmid: 21779725
references.citation: Alcohol Clin Exp Res. 2004 Jan;28(1):4-9
references.pmid: 14745296
references.citation: Behav Genet. 2006 Sep;36(5):640-50
references.pmid: 16622805
references.citation: Neuropharmacology. 2002 Sep;43(4):482-91
references.pmid: 12367595
references.citation: J Autism Dev Disord. 2009 Feb;39(2):223-30
references.pmid: 18821008
references.citation: Nature. 2007 Jun 7;447(7145):661-78
references.pmid: 17554300
references.citation: Front Syst Neurosci. 2011 Jul 14;5:59
references.pmid: 21808609
references.citation: Cereb Cortex. 2002 Oct;12(10):1063-70
references.pmid: 12217970
references.citation: Brain Res Brain Res Rev. 1998 May;26(2-3):113-35
references.pmid: 9651498
references.citation: J Neurophysiol. 2009 Oct;102(4):2312-25
references.pmid: 19625540
references.citation: Braz J Psychiatry. 2008 Sep;30(3):281-9
references.pmid: 18833430
references.citation: Anat Rec (Hoboken). 2011 Oct;294(10):1635-45
references.pmid: 21901840
references.citation: BMC Genet. 2005 Dec 30;6 Suppl 1:S143
references.pmid: 16451603
references.citation: Am J Med Genet. 1994 Mar 15;54(1):12-20
references.pmid: 8178835
references.citation: Genomics. 1994 Oct;23(3):528-33
references.pmid: 7851879
references.citation: Am J Med Genet. 1999 Oct 15;88(5):533-8
references.pmid: 10490712
references.citation: Psychiatry Res. 2012 Jul 30;198(2):202-6
references.pmid: 22414661
references.citation: Cereb Cortex. 1995 Nov-Dec;5(6):550-60
references.pmid: 8590827
references.citation: Mol Psychiatry. 2010 Feb;15(2):146-53
references.pmid: 19078961
references.citation: Genomics. 1994 Mar 15;20(2):285-8
references.pmid: 8020978
references.citation: Psychopharmacology (Berl). 2004 Jan;171(3):322-30
references.pmid: 13680072
references.citation: Biol Psychiatry. 2005 Sep 15;58(6):440-5
references.pmid: 15993854
references.citation: PLoS One. 2009 Sep 18;4(9):e6977
references.pmid: 19763268
references.citation: Neuropsychopharmacology. 2003 Jan;28(1):1-13
references.pmid: 12496935
references.citation: Am J Psychiatry. 2004 Oct;161(10):1822-8
references.pmid: 15465979
references.citation: Neuropharmacology. 1996;35(9-10):1139-60
references.pmid: 9014130
references.citation: Psychoneuroendocrinology. 2012 Apr;37(4):581-5
references.pmid: 21871738
references.citation: Schizophr Res. 2002 Nov 1;58(1):11-20
references.pmid: 12363385
references.citation: PLoS One. 2010 Mar 08;5(3):e9547
references.pmid: 20221451
references.citation: Alcohol Clin Exp Res. 2011 Mar;35(3):496-505
references.pmid: 21143246
references.citation: J Neurosci. 1992 Mar;12(3):1040-62
references.pmid: 1312131